Policy & Regulation
European Commission Purchases Additional 150m Doses of Moderna's COVID-19 Vaccine for Delivery in 2022
22 June 2021 - - The European Commission has purchased an additional 150m doses of US-based biotechnology company Moderna, Inc's (NASDAQ: MRNA) COVID-19 vaccine, including the ability to pur...
AstraZeneca and MSD's Koselugo gets EU approval in children with NF1
22 June 2021 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN) reported on Tuesday that Koselugo (selumetinib) has been granted conditional approval in the European Union fo...
RedHill Biopharma finds encouraging data from the Oral Opaganib Phase 2 study in COVID-19 patients
22 June 2021 - Biopharmaceutical company RedHill Biopharma Ltd (Nasdaq:RDHL) on Monday provided the data from its Phase 2 positive safety and efficacy data for oral opaganib in 40 hospitalised patient...
Fapon Biotech calls for cooperation of academic and industry partners for development of mucormycosis diagnostic tests
22 June 2021 - Biotechnology development company Fapon Biotech Inc reported on Monday that Mucormycosis (black fungus) is a devastating infection that continues to rise in India during the COVID-19 pa...
Hope Biosciences Stem Cell Research Foundation wins FDA's approval for simultaneous stem cell trials for Parkinson's Disease
22 June 2021 - Non-profit research company Hope Biosciences Stem Cell Research Foundation (HBSCRF) reported on Monday the receipt of Food and Drug Administration (FDA) authorisation for a free Phase I...
Gossamer Bio names Richard Aranda, MD as CMO
22 June 2021 - Biopharmaceutical company Gossamer Bio Inc (Nasdaq:GOSS) reported on Monday the appointment of Richard Aranda, MD as its chief medical officer.Prior to the promotion, Dr Aranda has serv...